Leukocyte esterase

Antech pioneers first automated rapid urine culture for cats and dogs

Retrieved on: 
Monday, January 11, 2021
Branches of biology, Medical specialties, Clinical medicine, Nephrology, Clinical urine tests, Bacteriuria, Urine, Urine tests, Leukocyte esterase

FOUNTAIN VALLEY, Calif., Jan. 11, 2021 /PRNewswire/ --Antech Diagnostics introduced today the first automated test for rapid, reliable urine culture results for cats and dogs.

Key Points: 
  • FOUNTAIN VALLEY, Calif., Jan. 11, 2021 /PRNewswire/ --Antech Diagnostics introduced today the first automated test for rapid, reliable urine culture results for cats and dogs.
  • The FIRSTract Urine Culture test offers highly sensitive, specificdetection of bacteriuria with results in 24 hours.
  • Supporting good antimicrobial stewardship, the FIRSTract Urine Culture test delivers highly specific, sensitive results faster than urinalysis followed by traditional urine culture, which are limited by sample collection issues and lengthy turn-around times.
  • Antech is offering FIRSTract Urine Culture test free of charge to all urine culture tests immediately.

LexaGene Reports on Successful Results from Beta Testing in Human Clinical Diagnostics Laboratory

Retrieved on: 
Thursday, September 19, 2019
Medical specialties, Medicine, Nephrology, Infectious diseases, Urine tests, Clinical medicine, Clinical urine tests, Urinary tract infection, Leukocyte esterase, Rosalind Maskell

ASL is a certified reference laboratory specializing in providing clinical testing results to physicians nationwide.

Key Points: 
  • ASL is a certified reference laboratory specializing in providing clinical testing results to physicians nationwide.
  • The laboratory processes over 300 urine samples per week for human urinary tract infections plus hundreds of other sample types.
  • LexaGene has now completed beta tests for urinary tract infections in both dogs and humans, uncovering very different infection profiles for both.
  • Dr. Jack Regan, CEO and Founder of LexaGene states, We are very pleased that our beta program is having such great success.